Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 4:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 4
1 (100.0%)Optimal Dose of Intravenous Oxycodone for Endotracheal Intubation
Phase 4
Completed
- Conditions
- Intubation ComplicationBlood Pressure
- Interventions
- Drug: salineDrug: 0.05 mg/kg of oxycodoneDrug: 0.2 mg/kg of oxycodoneDrug: 0.15 mg/kg of oxycodoneDrug: 0.1 mg/kg of oxycodone
- First Posted Date
- 2015-06-29
- Last Posted Date
- 2017-07-21
- Lead Sponsor
- Yong-Hee Park
- Target Recruit Count
- 95
- Registration Number
- NCT02484352
- Locations
- 🇰🇷
Department of Anesthesiology and Pain Medicine : Chung-Aung University Hospital, Seoul, Korea, Republic of
News
No news found